Optic neuropathies including glaucoma, traumatic injury, ischemic damage, and optic neuritis, are the leading causes of irreversible blindness worldwide; however, effective treatments for optic nerve ...

NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...

TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a biopharmaceutical company developing ...

When 75-year-old grandfather Dave Richards began a bike ride with friends in July 2021, he expected nothing more than a pleasant afternoon. But in a few chaotic seconds, his life changed forever. A ...

According to experts, a baby born today has a 40 per cent chance of living for 150 years, largely due to advances in medical technology ...

When it comes to eye health, the focus falls on vitamin A or omega-3 fats. But studies from the American Academy of ...

Scientists have created an advanced visual neuroprosthesis that communicates bidirectionally with the brain, marking one of ...

A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...

AxoGen ((AXGN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help ...

Detailed price information for Nurexone Biologic Inc (NRX-X) from The Globe and Mail including charting and trades.

Blindness profoundly affects people's lives. Around the world, several laboratories, including the Biomedical ...